# Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer

> **NCT00909441** · NA · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 153 (actual)

## Conditions studied

- Breast Cancer
- Invasive Breast Cancer

## Interventions

- **PROCEDURE:** Sentinel Lymph Node Biopsy

## Key facts

- **NCT ID:** NCT00909441
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-12
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2015-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909441, "Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00909441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*